Associacao Protectora dos Diabeticos de Portugal

APDP Diabetes Portugal brings to this project the expertise resulting of almost 100 years of experience working with people with diabetes, looking towards BEAMER for an innovative approach to overcome the fragmentation between different levels of health provision, while promoting training on patient education and empowerment, especially regarding those on insulin treatment.”

Health conditions and target population approached by APDP:

Adults diagnosed with Diabetes Type 2 on insulin regime. Experienced adherence challenges are patient adherence to therapeutic plan and to correct injection technique, perception regarding other injectables, fear of hypoglycaemia episodes, fear of weight gain, perception of second-line drug.

APDP-Diabetes Portugal is a non-profit organization, dean association of IDF –International Diabetes Federation. APDP is currently an international reference as a specialised clinic in the treatment of diabetes, developing actively the support of policy making and advocacy. It is also a model institution in terms of integrated care, providing specialised healthcare to more than 18.000 people with diabetes each year, training for healthcare professionals, and other professional and non-professional groups (medical students, people with diabetes, families, and informal carers). APDP can not only provide the patient view, but also to provide the professionals and managers of integrated care view. Team members participate frequently in the production of materials regarding therapeutic education

Associacao Protectora dos Diabeticos de Portugal

APDP Diabetes Portugal brings to this project the expertise resulting of almost 100 years of experience working with people with diabetes, looking towards BEAMER for an innovative approach to overcome the fragmentation between different levels of health provision, while promoting training on patient education and empowerment, especially regarding those on insulin treatment.”

Health conditions and target population approached by APDP:

Adults diagnosed with Diabetes Type 2 on insulin regime. Experienced adherence challenges are patient adherence to therapeutic plan and to correct injection technique, perception regarding other injectables, fear of hypoglycaemia episodes, fear of weight gain, perception of second-line drug.

APDP-Diabetes Portugal is a non-profit organization, dean association of IDF –International Diabetes Federation. APDP is currently an international reference as a specialised clinic in the treatment of diabetes, developing actively the support of policy making and advocacy. It is also a model institution in terms of integrated care, providing specialised healthcare to more than 18.000 people with diabetes each year, training for healthcare professionals, and other professional and non-professional groups (medical students, people with diabetes, families, and informal carers). APDP can not only provide the patient view, but also to provide the professionals and managers of integrated care view. Team members participate frequently in the production of materials regarding therapeutic education

Healthcare Professional

The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)

It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.

These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.

Patient Organisation

Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.

The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.

The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.

“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”